• SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) is set to report its quarterly earnings on April 23, 2026, with analysts forecasting EPS of $1.66 and revenue of $1.63 billion.
  • The SS&C GlobeOp Forward Redemption Indicator decreased to 1.26% in April, signaling reduced investor withdrawals from hedge funds.
  • The company's financial health includes a trailing twelve-month P/E ratio of 21.18 and a debt-to-equity ratio of 1.11.

SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) is a leading provider of financial technology solutions and services to the financial and healthcare industries. This investment management software company helps firms manage their investments and operations. SSNC is scheduled to report its quarterly earnings on April 23, 2026, after the market closes.

Wall Street analysts have set an earnings per share (EPS) estimate of $1.66 for SSNC. This would be a 15.3% increase from the same period last year. The consensus revenue estimate is approximately $1.63 billion, which represents a 7.7% year-over-year increase, as highlighted by Zacks, offering key investor insights into the company's growth trajectory.

Ahead of the quarterly financial results, the company's SS&C GlobeOp Forward Redemption Indicator for April 2026 measured 1.26%. This crucial indicator tracks requests by hedge fund investors to withdraw their funds. The April figure is a decrease from 1.90% in March, suggesting fewer investors are pulling money out and indicating positive hedge fund industry trends.

According to a report from Business Wire, CEO Bill Stone notes that "Favorable trends in hedge fund redemptions continued this month." He adds that in uncertain markets, hedge funds can help investors by offering diversification, which could boost demand for SSNC's financial services software.

The company's financial metrics show a trailing twelve-month Price-to-Earnings (P/E) ratio of 21.18. This key stock market analysis ratio compares the company's stock price to its earnings. SSNC also has a debt-to-equity ratio of 1.11, which measures how much debt a company uses to finance its assets compared to shareholder equity, providing a comprehensive view of its financial health.